HomePLX • NYSEAMERICAN
add
Protalix Biotherapeutics Inc
Nakaraang pagsara
$2.27
Sakop ng araw
$2.15 - $2.26
Sakop ng taon
$0.82 - $2.36
Market cap
161.99M USD
Average na Volume
488.85K
P/E ratio
-
Dividend yield
-
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 17.96M | 73.60% |
Gastos sa pagpapatakbo | 5.59M | -23.79% |
Net na kita | 3.24M | 274.73% |
Net profit margin | 18.02 | 200.67% |
Kita sa bawat share | — | — |
EBITDA | 4.32M | 373.07% |
Aktuwal na % ng binabayarang buwis | 15.79% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 27.41M | -33.11% |
Kabuuang asset | 61.56M | -29.70% |
Kabuuang sagutin | 29.13M | -40.95% |
Kabuuang equity | 32.44M | — |
Natitirang share | 73.63M | — |
Presyo para makapag-book | 5.16 | — |
Return on assets | 13.03% | — |
Return on capital | 21.49% | — |
Cash Flow
Net change in cash
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 3.24M | 274.73% |
Cash mula sa mga operasyon | 4.10M | 159.60% |
Cash mula sa pag-invest | 20.33M | 197.36% |
Cash mula sa financing | -20.42M | — |
Net change in cash | 4.01M | 114.44% |
Malayang cash flow | 1.05M | 113.52% |
Tungkol
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease. Wikipedia
CEO
Itinatag
1993
Headquarters
Website
Mga Empleyado
208
